0001213900-18-000044.txt : 20180102
0001213900-18-000044.hdr.sgml : 20180102
20180102170653
ACCESSION NUMBER: 0001213900-18-000044
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171229
FILED AS OF DATE: 20180102
DATE AS OF CHANGE: 20180102
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TAGLICH ROBERT
CENTRAL INDEX KEY: 0001353439
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-54748
FILM NUMBER: 18502536
MAIL ADDRESS:
STREET 1: 700 NEW YORK AVENUE
CITY: HUNTINGTON
STATE: NY
ZIP: 11743
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Icagen, Inc.
CENTRAL INDEX KEY: 0001518520
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 200982060
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4222 EMPEROR BLVD., SUITE 350
STREET 2: RESEARCH TRIANGLE PARK
CITY: DURHAM
STATE: NC
ZIP: 27703
BUSINESS PHONE: 919-941-5206
MAIL ADDRESS:
STREET 1: 4222 EMPEROR BLVD., SUITE 350
STREET 2: RESEARCH TRIANGLE PARK
CITY: DURHAM
STATE: NC
ZIP: 27703
FORMER COMPANY:
FORMER CONFORMED NAME: XRpro Sciences, Inc.
DATE OF NAME CHANGE: 20141204
FORMER COMPANY:
FORMER CONFORMED NAME: Caldera Pharmaceuticals Inc
DATE OF NAME CHANGE: 20110419
4
1
f4122917taglichr_icagen.xml
OWNERSHIP DOCUMENT
X0306
4
2017-12-29
0
0001518520
Icagen, Inc.
NONE
0001353439
TAGLICH ROBERT
C/O ICAGEN, INC. 4222 EMPEROR
BLVD., SUITE 350, RESEARCH TRIANGLE PARK
DURHAM,
NC
27703
1
0
1
0
Common Stock, $0.001 par value
2017-12-29
4
P
0
21429
0.37
A
72125
D
Common Stock, $0.001 par value
301714
I
See footnote
Warrant
3.50
2017-12-29
4
A
0
5357
0.02
A
2017-12-29
2019-12-31
Common Stock
5357
5357
D
Mr. Taglich indirectly owns an aggregate of 301,714 shares of common stock of Icagen, Inc. as follows: (i) 285,714 shares held in Mr. Taglich's individual retirement account; and (ii) an aggregate of 16,000 shares held by four separate custodial accounts for the benefit of Mr. Taglich's minor children.
/s/ Robert Taglich
2018-01-02